Gland Pharma Limited’s board announced the appointment of Shyamakant Giri as its new CEO, effective January 15, 2025. Giri, currently serving as the President (India Business and Emerging Markets) at Amneal Pharmaceuticals, has been instrumental in driving commercial growth and expansion in India and other global markets. As reported by cnbctv18.com, Srinivas Sadu will continue as the executive chairman, guiding the company through its next phase of growth.
